ClinicalTrials.Veeva

Menu

Management of Diabetes Mellitus Patients With Retinopathy

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Retinopathy
Diabetes Mellitus

Study type

Observational

Funder types

Industry

Identifiers

NCT00828425
NIS-CCH-DUM-2008/1

Details and patient eligibility

About

Aim of this NIS is to retrospectively document the management of diabetic patients with retinopathy in a naturalistic setting in Switzerland. Following elements are going to be analyzed:

  • which medication are used to keep blood pressure under control?
  • which medication are used for metabolic control?
  • the average control level of metabolism and blood pressure is compliant with the international guidelines?
  • laser photocoagulation plays a role in the control of metabolism and blood pressure?
  • there are differences in the control of metabolism and blood pressure between patients with DM I or DM II?
  • there is an influence of renal failure on the choose of medication?

Enrollment

2,500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Diabetic patients
  • Diabetic retinopathy

Trial design

2,500 participants in 1 patient group

1
Description:
Diabetic patients with retinopathy

Trial contacts and locations

62

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems